Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | $9.76B | 189.9x | 1.02 | $28.96 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -13.7% Downside | Upgrade to Pro+ | |
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | $3.98B | -21.8x | -1.85 | $3.13 | 7.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -26.5% Downside | Upgrade to Pro+ | |
Opthea | Sydney | Healthcare | Biotechnology & Medical Research | $1.39B | -2.1x | 0.55 | $1.13 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.6% Upside | Upgrade to Pro+ | |
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | $1.19B | -44.3x | 0.44 | $3.69 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PYC Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $585.59M | -13.1x | 0.43 | $1.25 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | $487.62M | -9.4x | -0.58 | $0.34 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AVITA Medical | Sydney | Healthcare | Biotechnology & Medical Research | $365.81M | -0.8x | 0.06 | $2.92 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.3% Upside | Upgrade to Pro+ | |
Imugene Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $275.93M | -1.7x | 0.01 | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dimerix | Sydney | Healthcare | Biotechnology & Medical Research | $256.85M | -12.1x | -1.33 | $0.46 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Race Oncology | Sydney | Healthcare | Biotechnology & Medical Research | $210.19M | -14.6x | 0.45 | $1.21 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arovella Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $206.58M | -21.7x | -0.66 | $0.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CogState Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $203.87M | 23.9x | 0.41 | $1.19 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.8% Upside | Upgrade to Pro+ | |
Paradigm Biopharmaceuticals Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $194.71M | -2.5x | -1.04 | $0.50 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LTR Pharma | Sydney | Healthcare | Biotechnology & Medical Research | $125.78M | -14.8x | 0.03 | $0.70 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Actinogen Medical | Sydney | Healthcare | Biotechnology & Medical Research | $97.12M | -5x | 12.25 | $0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Argenica Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $93.51M | -15.1x | -0.88 | $0.73 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioxyne Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $84.02M | -6x | 0.02 | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Proteomics Intl Labs | Sydney | Healthcare | Biotechnology & Medical Research | $81.88M | -12.3x | -2.96 | $0.63 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -20% Downside | Upgrade to Pro+ | |
Alterity Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $63.84M | -2.4x | -0.43 | $0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cynata Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $58.56M | -4.8x | -0.12 | $0.26 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IDT Australia Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $47.28M | -6.9x | -0.17 | $0.11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tryptamine Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $47.23M | -2.3x | -0.45 | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anteo Diagnostics | Sydney | Healthcare | Biotechnology & Medical Research | $45.99M | -4.3x | -0.14 | $0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurotech Intl | Sydney | Healthcare | Biotechnology & Medical Research | $45.85M | -7.3x | -0.23 | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pacific Edge | Sydney | Healthcare | Biotechnology & Medical Research | $44.69M | -1.8x | -0.18 | $0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prescient Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $41.07M | -5.1x | 0.86 | $0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amplia Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $29.45M | -3x | 0.24 | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Noxopharm | Sydney | Healthcare | Biotechnology & Medical Research | $27.76M | -7.9x | -0.1 | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clever Culture Systems | Sydney | Healthcare | Biotechnology & Medical Research | $26.40M | -4x | -0.08 | $0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhythm Biosciences | Sydney | Healthcare | Biotechnology & Medical Research | $24.39M | -2.8x | -0.19 | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Island Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | $23.61M | -2.5x | -1.21 | $0.13 | -7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tissue Repair | Sydney | Healthcare | Biotechnology & Medical Research | $18.74M | -6.3x | -5.21 | $0.31 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BTC Health | Sydney | Healthcare | Biotechnology & Medical Research | $18.15M | 18.7x | 0.15 | $0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Emyria | Sydney | Healthcare | Biotechnology & Medical Research | $15.66M | -1.4x | 0.02 | $0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medlab Clinical Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $15.07M | -7.1x | -0.1 | $6.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avecho Bio | Sydney | Healthcare | Biotechnology & Medical Research | $11.09M | -4x | -0.09 | $0.004 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chimeric Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $11.03M | -0.6x | -0.01 | $0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BPH Energy Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $10.96M | 2.3x | 0.01 | $0.009 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invion Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $10.55M | -1.6x | 0.01 | $0.15 | 6.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Algorae Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | $10.12M | -6x | -0.26 | $0.006 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adalta | Sydney | Healthcare | Biotechnology & Medical Research | $10.10M | -1.5x | -0.07 | $0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biotron Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $9.02M | -2.8x | -0.4 | $0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Holista CollTech Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $8.57M | -1.8x | 0.01 | $0.03 | 41.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Percheron Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $7.61M | -0.5x | -0.04 | $0.007 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.9% Upside | Upgrade to Pro+ | |
Zelira Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $5.90M | -0.2x | 0 | $0.52 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neuroscientific Biopharma | Sydney | Healthcare | Biotechnology & Medical Research | $5.64M | 19.5x | 0.13 | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invex Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | $5.49M | 48.3x | -0.04 | $0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Patrys Ltd | Sydney | Healthcare | Biotechnology & Medical Research | $5.14M | -1.5x | -0.03 | $0.003 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cambium Bio | Sydney | Healthcare | Biotechnology & Medical Research | $4.91M | -390x | $0.37 | -5.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Vectus Biosystems | Sydney | Healthcare | Biotechnology & Medical Research | $4.31M | -1.8x | -0.05 | $0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |